Press releases 2009

16 January 2009

TR - 1: NOTIFICATION OF MAJOR INTERESTS IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Futura Medical Plc

2. Reason for the notification (please tick the appropriate box or boxes)

 

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify): Fresh Start notification in the context of reallocation and threshold related recalculation of reportable holdings due to the new formation of Allianz Group and Commerzbank Group

 

3. Full name of person(s) subject to the notification obligation:

Allianz SE

4. Full name of shareholder(s) (if different from 3.):

Allianz Insurance plc

5. Date of the transaction (and date on which the threshold is crossed or reached if different):

12 January 2009

6. Date on which issuer notified:

15 January 2009

7. Threshold(s) that is/are crossed or reached:

7%

8. Notified details:

 

 

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights ix

% of voting rights

Direct

Direct x

Indirect xi

Direct

Indirect

GB0033278473

 

 

 

 

4,133,835

 

7.17%

B: Financial Instruments

Resulting situation after the triggering transaction xii

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period/ Date xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

Total (A+B)

 

Number of voting rights

% of voting rights

4,133,835

7.17%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable xv:

Allianz SE is the ultimate holding company of Allianz Europe Ltd, which is the major holding company of Allianz (UK) Limited, which is the holding company of Allianz Holdings Plc, which is the major holding company of Allianz Insurance Plc.


Proxy Voting:

 

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease to hold:


12. Date on which proxy holder will cease to hold voting rights:


13. Additional information:


Fresh Start notification in the context of reallocation and threshold related recalculation of reportable holdings due to the new formation of Allianz Group and Commerzbank Group


14. Contact name:

Allianz SE Group Compliance

15. Contact telephone number:

+49 89 38 0017879

Annex Notification Of Major Interests In Shares xvi

A: Identity of the person or legal entity subject to the notification obligation

 

Full name (including legal form for legal entities)

Allianz SE

Contact address (registered office for legal entities)

Koeniginastrasse 28
80802 Munich
Germany

Phone number

+49 89 3800 17879

Other useful information (at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable xvii

Full name

Allianz SE Group Compliance

Contact address

Koeniginstrasse 28
80802 Munich
Germany

Phone number

+49 89 38 0017879

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

 


 

C: Additional information

 

 

 

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
Nomura Code Securities Limited
Phil Walker / Giles Balleny
Tel: +44 (0) 20 7776 1200

For media enquiries please contact:

Buchanan Communications Limited
Mark Court / Stasa Filiplic / George Prassas

Tel: +44 (0) 20 7466 5000